Emel Bayar

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies

Jean‐Pierre J. Issa, Guillermo Garcia‐Manero, Francis J. Giles et al. · Blood · 2003 · 817 citations

Medicine, Oncology, Pharmacology +14

Is There a Potential Role for Serum Cardiac Troponin I as a Marker for Myocardial Dysfunction in Pediatric Patients Receiving Anthracycline-Based Therapy? A Pilot Study

Prasad Mathew, William A. Suarez, K. T. Kip et al. · Cancer Investigation · 2001 · 32 citations

Medicine, Cardiology, Pediatrics +17

Decitabine: development of a DNA methyltransferase inhibitor for hematological malignancies.

John F. Lyons, Emel Bayar, Gil D. Fine et al. · PubMed · 2003 · 31 citations

Medicine, Oncology, Pharmacology +17

Monozygotic twins with congenital acute lymphoblastic leukemia (ALL) and t(4;11)(q21;q23)

Emel Bayar, Thaddeus W. Kurczynski, Margaret G. Robinson et al. · Cancer Genetics and Cytogenetics · 1996 · 18 citations

Life Sciences, Genetics, Hematology +14